Alnylam Pharmaceuticals is responsible for the funding and content of this website. The site is intended for Healthcare Professionals in Europe, Middle East and Africa. For disease awareness purposes only.

Think PH1 Logo
For Patients
Sign up for updates
MENU

ADDITIONAL RESOURCES ON PH1

Find links to advocacy organisations, information on testing and research resources, and primary hyperoxaluria type 1 (PH1) educational materials below.

TESTING AND DISEASE INFORMATION

One option for genetic testing for PH1

Alnylam Pharmaceuticals sponsors third-party genetic testing and counselling for individuals who may carry gene mutations known to be associated with PH1.

DOWNLOADS AND VIDEOS

Videos

Play Video about When Kidney Stones May Be A Sign Of Something More Serious Video Thumbnail

When kidney stones may be a sign of something more serious1

Learn about when a systemic condition may be behind kidney stone formation and how genetic testing can help confirm a diagnosis.1
Play Video about PH1 Mechanism of Disease Video Thumbnail

PH1 mechanism of disease

Learn how genetic mutation leads to PH1 and its complications1,2
Play Video about Zoe PH1 Patient Story Video Thumbnail

Patient perspectives: Zoe describes life with PH1

After a history of kidney stones, a serious health event led to Zoe’s diagnosis of PH1. Watch Zoe explain what her genetic disease means for her and her family.
Play Video about Margarita and Her Son's Journey to PH1 Diagnosis Video

Patients perspectives: Margarita describes her son's journey to a PH1 diagnosis and beyond

Margarita knew something was wrong with her son, Mario, when he was three years old. Following his PH1 diagnosis, Margarita became a founding member of APHES, a PH1 patient association in Spain.

Reference materials

PH1 Brochure

When kidney stones may be a sign of something more serious. An overview of this metabolic stone disease.
Download

Can you spot the signs of PH1?

A one-page infographic detailing the signs of hyperoxaluria.
Download

PH1 handbook for patients

A guide booklet for patients to help them manage life with PH1.
Download

PH1 guide for caregivers

A helpful guide for caregivers of children with PH1.
Download

PH1 information sheet

A single-page handout for patients to share with others to help them understand PH1.
Download

How to diagnose PH1

Information about the PH1 hallmark clinical signs, the additional investigations to be carried out and the recommended procedure in case of hyperoxaluria.
Download

Quick guide to genetic disorders of urolithiasis

Information about diagnosing genetic disorders of urolithiasis, including key signs and a kidney stone composition analysis. Produced in collaboration with a nephrologist and a urologist.
Download

ADVOCACY AND PROFESSIONAL ORGANISATIONS

Oxalosis & Hyperoxaluria Foundation (OHF) Logo

Oxalosis & Hyperoxaluria Foundation (OHF)

OHF supports clinicians and patients in the hyperoxaluria community through education, advocacy, and grants and funding for research.
Visit Website
European Hyperoxaluria Consortium OxalEurope Logo

European Hyperoxaluria Consortium OxalEurope

OxalEurope serves as a hyperoxaluria-centered consortium providing clinical guidelines for screening, guidance, diagnosis, and treatment for PH1.
Visit Website

Testing patients for PH1

See how genetic testing plays an important role in a PH1 diagnosis.1,3
Testing Options

Get Updates

Sign up to receive information from Alnylam about PH1
Sign Up

References: 1. Milliner DS, Harris PC, Cogal AG, Lieske JC. https://www.ncbi.nlm.nih.gov/books/NBK1283/. Updated February 10, 2022. Accessed October 2023.  2. Cochat P, Rumsby G. N Engl J Med. 2013;369(7):649-658.  3. Cochat P, Hulton SA, Acquaviva C, et al. Nephrol Dial Transplant. 2012;27(5):1729-1736.

PH1-CEMEA-00130 | November 2023

TAKE ME TO DISCOVER PH1
Alnylam Pharmaceuticals Logo

ThinkPH1 is a trademark of Alnylam Pharmaceuticals, Inc.
©2023 Developed and produced by Alnylam Switzerland GmbH. All rights reserved.

PH1-CEMEA-00124

November 2023

Alnylam Pharmaceuticals is responsible for the funding and content of this website. The site is intended for Healthcare Professionals in Europe, Middle East and Africa. For disease awareness purposes only.

Think PH1 Logo
CLOSE
Sign up for updates
For Patients

Welcome to the ThinkPH1.eu Healthcare Professional website.

By accessing the website, you confirm to be a Healthcare Professional from Europe, Middle East, or Africa:
OK

If you are not a Healthcare Professional, please access the LivingwithPH1.eu website here.

You are now leaving ThinkPH1

The following content may not be associated with Alnylam Pharmaceuticals. Links to all outside sites are provided as a reference for our visitors. Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Close